Comparison of Seroconversion Rates with Three Kinds of Recombinant Hepatitis B Vaccines
スポンサーリンク
概要
- 論文の詳細を見る
The seroconversion rate after vaccination may vary with age, type of vaccine, and injection method. In this study, the seroconversion rates of 3 kinds of recombinant HB vaccines were examined in dental students matched for age and sex. In 605 dental students, who were negative for anti-hepatitis B surface antibody, anti-hepatitis B surface antibody was measured after inoculation of with 3 kinds of vaccines; Bimmugen, r-HB vaccine"MITSUBI-SHI", and Engerix-B; and the seroconversion rate was calculated. The seroconversion rates after inoculation with these vaccines were 91 %, 88% and 96.6%, respectively. The overall seroconversion rate was 93%, and the rate of Engerix-B seroconversion was significantly higher than those of the two other vaccines. The seroconversion rate in males was 90%, and 96% in females. These results suggest that improved dosages and selection of the type of vaccine used in HB vaccination is necessary.
- 昭和大学・昭和医学会の論文
昭和大学・昭和医学会 | 論文
- 病理検体（ホルマリン固定パラフィン包埋組織切片）を用いた感染症遺伝子診断：結核菌Mycobacterium tuberculosis
- リンパ形質細胞性リンパ腫 / Waldenströmマクログロブリン血症
- 大学での30年間を振り返り
- 摂食・嚥下障害のリハビリテーションその包括的対応
- 原発性肝癌肝切除後の根治的治療不能残肝再発例に対するCDDP+5-FUによる肝動注療法の経験 : ―静止療法としての抗腫瘍効果と副作用―